Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1196-1205
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1196
Table 4 Characteristics of the patients -nucleotide-binding oligomerization domain 2 status, classification and activity of the disease, C-reactive protein and vitamin D levels, and medication at the time of the study
No.SexAgeNOD2Montreal classificationCDAICRP (mg/L)Vitamin D (nmol/L)Prednisolon (> 10 mg/d)Azathio-prineAnti-TNF-α
1M24WT1A2 L3 L4 B11212.58104.0YesNoYes
2M28WT1A2 L3 B3p46< 1.062.9NoNoYes
3M64WT1A3 L3 B2p1114.5827.0YesNoYes
4F60WTA2 L3 B21002.2772.5NoNoYes
5F62WTA3 L3 B3p82< 1.058.2YesYesYes
6M46WTA2 L3 L4 B2p1104.9732.9NoNoYes
7M38HOA2 L3 B3p9213.3040.2NoYesNo
8M64HOA3 L3 B134< 1.053.0NoNoYes
9F48HO2A2 L3 B254< 1.067.6NoNoYes
10M54HOA2 L3 B2p1031.6351.9NoYesNo
11M26HOA1 L3 B2p1207.8631.0NoYesYes
12M27HTA2 L3 B11061.4147.2NoNoYes
13M37HTA2 L3 B2p1664.5637.9NoYesNo
14F48HTA2 L1 B3p1151.0155.2NoYesYes
15M57HTA1 L3 B2p13212.3052.3NoNoYes
16M47HTA2 L3 B3602.6292.0NoYesNo